Loading provider…
Loading provider…
Hematology & Oncology Physician in Lone Tree, CO
NPI: 1306820022Primary Employer
Rocky Mountain Cancer Centers LLP
rockymountaincancercenters.com
HQ Phone
Get MD Michele's Phone Numberphone_androidMobile
Get MD Michele's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
CO State Medical License
1998 - 2027

American Board of Internal Medicine
Medical Oncology
University of Colorado
Fellowship • Hematology and Medical Oncology
2000 - 2002
Fellowship • Geriatric Medicine (Internal Medicine)
1999 - 2000
Residency • Internal Medicine
1996 - 1999
UCSF School of Medicine
medschool.ucsf.edu
Medical School
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 276 | 591 |
| 2 | 82378Carcinoembryonic antigen (CEA) protein level | 274 | 666 |
| 3 | 86300Immunologic analysis for detection of tumor antigen | 268 | 650 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 229 | 310 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 206 | 469 |
Barriers to enrollment of elderly adults in early-phase cancer clinical trials.
Authors: Sue Eckhardt, Lodovico Balducci
Journal: J Oncol Pract
Re: Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
Authors: Basche, M, Byers, T
Journal: J Natl Cancer Inst
Authors: Sue Eckhardt, Christopher Lieu
Journal: Cancer Chemother Pharmacol
Publication Date: 2008-05-29
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: laboratory biomarker analysis, OTHER: pharmacological study, DRUG: gefitinib, DRUG: capecitabine
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: laboratory biomarker analysis, OTHER: pharmacological study, DRUG: cilengitide